Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zhejiang Dongri Pharmaceutical Co., Ltd. is a comprehensive pharmaceutical enterprise based in Wenzhou, China, specializing in the research, development, and manufacturing of chemical APIs and finished dosage forms. The company's product portfolio includes a wide range of generic medications across therapeutic areas such as endocrinology, cardiovascular health, and anti-infectives. With a focus on high-quality manufacturing, the company operates GMP-certified facilities producing tablets, capsules, and granules for both domestic and international markets. Key products include metformin hydrochloride and various antibiotics, positioning the firm as a reliable supplier in the generic drug sector. The company maintains a strong presence in the regional Chinese market while expanding its reach through export-oriented API production.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zhejiang Dongri Pharmaceutical.